- Home
- EDSA vs ZTEK Comparison
EDSA vs ZTEK Comparison
Compare EDSA & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDSA | ZTEK |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.1M | 59.5M |
| IPO Year | 2018 | 2022 |
Fundamental Metrics
Financial Performance| Metric | EDSA | ZTEK |
|---|---|---|
| Price | $5.68 | $0.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 95.4K | ★ 263.8K |
| Earning Date | 05-08-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $0.37 |
| 52 Week High | $20.32 | $1.24 |
Technical Indicators
Market Signals| Indicator | EDSA | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 35.31 | 59.85 |
| Support Level | $4.87 | $0.55 |
| Resistance Level | $6.58 | $0.56 |
| Average True Range (ATR) | 0.53 | 0.05 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 1.63 | 76.11 |
Price Performance
Historical ComparisonAbout EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About ZTEK Zentek Ltd.
Zentek Ltd is engaged in developing opportunities in the graphene and related nano-materials industry based on its intellectual property, patents, and Albany graphite. The Company's operating segments are Intellectual Property Development, Biotech, and Albany Project. Intellectual Property Development includes the manufacturing and distribution of graphene-related products. Biotech includes service revenue generated through aptamer technology. The Albany Project includes the exploration and evaluation of assets and mineral exploration activities.